カジ旅 登録方法を図解で徹底解説【2024 版】注意点・やり方 ...

MENU Company Company Back Company Message from Top Management Our Founding Spirit Brand Statement Our Story Our History of Value Creation Vision and Strategy Framework Group Vision Long-Term Management Strategy Management Policy Medium-Term Management Plan Corporate Information and Business Sites Business Overview Introduction of Executives Corporate Governance Group Companies Procurement Policy Corporate Policy over Internal Control Integrated Report Products and Technology Products Back Products Search by Application Mobility Architectural Materials Infrastructure / General Industry Electronics Semiconductors Energy Daily commodities, Food industry Life Science Search by Business Category Architectural Glass Automotive Display Electronic Materials Essential Chemicals Performance Chemicals Life Science Ceramics New Business Search by Name Search by Keyword Technology and Innovation back Technology and Innovation A Message from the Chief Technology Officer Technology Development Strategy Intellectual Property Strategy R&D Structure Core Technologies Technology Highlights Mobility Electronics Life Science AGC Yokohama Technical Center AGC OPEN SQUARE “AO” Overview Facility Guide Access Collaboration Research Collaboration System R&D Library Measures to Prevent Misconduct in Research and Properly Manage Public Research Funds Sustainability Sustainability Back Sustainability Protecting the Global Environment and Utilizing Resources Supporting the Evolution of Cities and Mobility Realizing Longevity Society Where People Can Live in Good Health Creating a Healthy and Secure Society through Connections Generating New Value from Fair and Safe Workplaces Message from the President and CEO The AGC Group’s Sustainability Management Sustainability Promotion System Download Report Site Reports External Evaluations GRI Standards Index Sustainability-related policies, criteria, and guidelines AGC Group Code of Conduct/Compliance Help Lines Investors Investors Back Investors Management Information To Our Shareholders Vision and Strategy Framework Business Risks Disclosure Policy Financial Highlights IR News IR Library Company Overview Presentations of Financial Results Presentations of Business Briefings Financial Results Financial Review AGC Review (Newsletter for Shareholders) ESG Information Sustainability Corporate Governance Integrated Report Stock and Bond Information Stock Information Corporate Bond and Rating Information Dividend Information Analyst Coverage General Meeting of Shareholders Methods for Various Stock Procedures Electronic Public Notice Articles of Incorporation Stock Price Contact Us FAQ IR Email News Support Information IR Calendar Cautionary Statement IR Site Map Careers News Contact EN JP CN Search June 1, 2020Management Download PDF Print Consob has approved the Offer Document relating to the voluntary tender offer launched by AGC Inc. on the ordinary shares of MolMed S.p.A. The acceptance period of the Offer shall begin at 8.30 a.m. CET on June 1, 2020 and shall end at 5.30 p.m. CET on July 24, 2020, inclusive (unless extended, in accordance with applicable law). AGC Inc. (“AGC”) informs that CONSOB, by resolution no. 21391 of May 29, 2020, approved, pursuant to article 102, paragraph 4, of Legislative Decree no. 58 of 24 February 1998, as subsequently amended (the “CLFI”), the offer document (the “Offer Document”) relating to the totalitarian voluntary tender offer (the “Offer”) launched by AGC Biologics Italy S.p.A. (the “Offeror”), a corporate vehicle fully owned by AGC, pursuant to and for the purposes of article 102 et seq. of the CLFI, on maximum no. 463,450,672 ordinary shares of MolMed S.p.A. (“MolMed” or the “Issuer”), representing the entire share capital of the Issuer in circulation at the date of this press release. The acceptance period of the Offer shall start at 8.30 a.m. CET on June 1, 2020 and shall end at 5.30 p.m. CET on July 24, 2020, inclusive (unless extended, in accordance with applicable law). The price of the Offer, equal to EUR 0.518 for each MolMed share tendered to the Offer, shall be paid to those accepting the Offer on July 31, 2020 (unless extended, in accordance with applicable law). * * * The Offer Document relating to the totalitarian voluntary public tender offer launched by AGC Biologics Italy S.p.A. on maximum no. 463,450,672 ordinary shares of MolMed S.p.A. has been published In relation to the Offer, AGC also informs that the Offer Document, containing precise description of the terms and conditions of the Offer, as well as, inter alia, the modalities for acceptance to the Offer, has been published on May 29, 2020 and is available to the public for consultation: (i) at the registered office of the Offeror at Corso Vercelli, 40, Milan; (ii) at the registered office of the Issuer at Via Olgettina, 58, Milan; (iii) at the registered office of the Intermediary Responsible for Coordinating the Collection of the Acceptances, Banca IMI S.p.A. (at Largo Mattioli no. 3, Milan); (iv) on the Issuer's website (https://www.molmed.com/); (v) on the AGC website (https://www.agc.com/en/ir/stock/notice/index.html); and (vi) on the global information agent Morrow Sodali S.p.A.'s website (https://morrowsodali-transactions.com/molmed-s-p-a-/eng). It is also disclosed that the Issuer's notice pursuant to article 103, paragraph 3, of the CLFI is attached to the Offer Document. *NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. Reference Information About the AGC Group AGC Inc.(Headquarters: Tokyo, President & CEO: Takuya Shimamura) is the parent company of the AGC Group, a world-leading glass solution provider and supplier of flat, automotive and display glass, chemicals, ceramics and other high-tech materials and components. Based on more than a century of technical innovation, the AGC Group has developed a wide range of cutting-edge products. The AGC Group employs some 55,000 people worldwide and generates annual sales of approximately 1.5 trillion Japanese yen through business in about 30 countries. For more information, please visit www.agc.com/en MEDIA INQUIRIES Kazumi Tamaki, General Manager, Corporate Communications & Investor Relations DivisionAGC Inc. Contact: Yuki Kitano TEL: +81-3-3218-5603 E-mail: [email protected] Share News Index HomeNewsConsob has approved the Offer Document relating to the voluntary tender offer launched by AGC Inc. on the ordinary shares of MolMed S.p.A. Check in AGC Site Map About Social Media Contact About This Site Privacy Policy ©AGC Inc.